Melatonin administration during the dry period stimulates subsequent milk yield and weight gain of offspring in subtropical does kidding in summer

Effects of Implanting Exogenous Melatonin 40 Days before Lambing on Milk and Colostrum Quality

The effects of exogenous melatonin implanted before lambing on the quality of colostrum and milk yield were quantified in 715 ewes. Forty days before lambing, 246 ewes (1M) received a melatonin implant; another 137 ewes (2M) received two implants, and the remaining 332 ewes (C) did not receive an implant (control). Milk analysis was based on individual monthly milk samplings (June, July, and August) after lambing. A colostrum sample was collected from 303 ewes (118 1M; 73 2M; and 112 C), and IgG concentrations were measured. Ewes implanted with melatonin had higher (p < 0.01) daily milk yield (DMY) in the three samplings than the C ewes. On average, 1M ewes produced more milk (p < 0.05) than ewes in the other two groups, and 2M ewes produced significantly (p < 0.05) more milk than C ewes. In the first and third controls, ewes that received two melatonin implants had a lower (p < 0.05) SCC than C and 1M ewes, and in the second sampling, 1M and 2M ewes had a lower (p < 0.01) SCC than C ewes. Ewes that received melatonin implants had a higher (p < 0.01) IgG concentration (21.61 ± 1.03 mg/mL) than non-implanted ewes (16.99 ± 1.13 mg/mL); 2M ewes had the highest IgG levels. In conclusion, ewes that received a melatonin implant 40 d before lambing produced colostrum that had a higher IgG concentration than the colostrum from nonimplanted ewes, and produced more milk, which had a lower SCC. The effect on SCC was prolonged if the sheep received a second melatonin implant.

Responses to melatonin of 2 breeds of dairy ewes in early lactation under autumn photoperiod conditions

A total of 72 dairy ewes of 2 breeds (MN, Manchega, 72.4 ± 1.9 kg of body weight, n = 36; LC, Lacaune, 77.7 ± 2.3 kg of body weight; n = 36) were used to evaluate the lactational effects of melatonin implants in early lactation and under the short-day photoperiod conditions of autumn (experiment was centered on the winter solstice). Ewes lambed in autumn and were penned indoors in 12 balanced groups of 6 ewes by breed, body weight, age, and number of lambs, and randomly assigned to a 2 × 2 × 3 factorial design (treatment × breed × replicate). Ewes suckled their lambs for 28 d. Treatments were (1) melatonin (MEL), which received 1 subcutaneous implant of melatonin (18 mg/ewe) in the ear base at 35 ± 1 d (1 wk after lamb weaning), and (2) control, which did not receive any treatment. Ewes were fed ad libitum a total mixed ration (forage:concentrate, 60:40) and machine milked twice daily. Daily milk yield was automatically recorded from d 29 to 105 of lactation and sampled every 2 wk for composition. Jugular blood was sampled for plasma hormone analyses at 30, 50, 80, 110, and 124 d of lactation. Body reserves were assessed every 2 wk. Feed intake was measured by pen during 3 separated periods after the start of the treatments (wk 2 to 3, wk 6 to 7, and wk 10 to 11). Feed intake, and milk yield and composition varied by breed, but no MEL effects were detected on dry matter intake, milk yield, milk composition, or fat and protein standardized milk in either breed. As a result of the unique composition of the implants and the variable body weights of the ewes, the MEL treatment dose (on average, 0.24 mg/kg of body weight) was 6.8% greater in the MN (lighter) than in the LC (heavier) ewes. Plasmatic melatonin markedly increased in the MEL-treated ewes (on average, 111%), but despite the amount of MEL used, the MN responded greatly compared with the LC ewes (150 vs. 63%, respectively). No differences in basal plasmatic melatonin were detected between breeds (6.4 ± 1.1 pg/mL, on average), indicating the greater responsiveness to the implants of the lighter MN ewes. Plasmatic prolactin tended to decrease in the MEL-treated ewes (-35%, on average), but the effect was significant only in the MN ewes (-54%), in agreement with their greater response to MEL. No effects of MEL treatment were detected on plasmatic IGF-I in either breed. Moreover, body reserves did not vary by effect of MEL treatment or breed throughout the experiment. In conclusion, the use of exogenous melatonin as MEL implants, together with the endogenous melatonin naturally produced under short-day photoperiod conditions, had no effects on the early-lactation performances of dairy sheep, despite their breed and level of production.

The role of melatonin implantation and the associated effect of insulin-like growth factor-1 on milk composition of Barki ewes

ContextManipulation of milk composition in lactating ewes represents an important mechanism by which sheep breeders can improve profits through increased milk prices for cheese making and higher lamb growth rates. To this end, melatonin implantation may affect milk composition by alleviating reproductive seasonality and augmenting insulin like growth factor-1 (IGF-1).AimsThis research aimed to evaluate the effects of melatonin administration on hormone levels and milk composition, and to determine its potential to manipulate milk composition of lactating Barki ewes.MethodsFifty lactating Barki ewes were divided into two groups of 25. One group received 18mg melatonin in a single implant at 40 days after delivery, and the other group served as an untreated control. Over the following 8 weeks, milk components (fat, protein, lactose and total solids percentages), milk energy value, and blood serum hormones including IGF-1 were measured.Key resultsMelatonin implantation increased (P&lt;0.05) IGF-1 concentration, which showed continued elevation (P&lt;0.05) throughout the treatment period (from Day14 to Day56) relative to the control. Analysis of milk composition of implanted ewes revealed higher (P&lt;0.05) milk fat, protein, lactose and total solids percentages as well as milk energy value than in milk of control ewes.ConclusionAn integrated effect of melatonin and IGF-1 successfully improved milk composition of lactating Barki ewes.ImplicationsMelatonin implantation can be used to improve milk composition of lactating Barki ewes, potentially increasing profits from cheese making and lamb production.

Implanting melatonin at lambing enhances lamb growth and maintains high fat content in milk

Three experiments were designed to study the effects of melatonin implantation of ewes and lambs after lambing on the growth of lambs and milk quality throughout lactation. In experiment 1, 53 lambs either did (n = 28) or did not (n = 25) receive a subcutaneous 18-mg melatonin implant at the base of the left ear. In experiment 2, 55 lambs and their mothers either did (lambs: n = 28; ewes: n = 15) or did not (lambs: n = 27; ewes: n = 16) receive a melatonin implant. Milk samples were collected at 15, 30, and 45 d after lambing. In experiment 3, 16 lambs were separated from their mothers 24 h after birth, moved to an artificial rearing unit, and either did (n = 9) or did not (n = 7) receive a melatonin implant. In the three experiments, implants were inserted 24 h after lambing, and lambs were weighed (LW) weekly until weaning (for each experiment, 7, 6, and 5 wk., respectively). Average daily gains (ADG) from birth to weaning were calculated. Melatonin treatment of lambs did not have a significant effect on LW at weaning or ADG, but lambs reared by implanted ewes in experiment 2 presented higher (P < 0.05) LW (±S.E.M.) at weaning (implanted: 13.61 ± 0.51; non-implanted: 12.09 ± 0.57 kg) and ADG (implanted: 221.00 ± 10.45; non-implanted: 189.92 ± 12.44 g/d) than did lambs reared by control ewes. At day 45 of lactation, milk fat and total solid content were higher (P < 0.05) in implanted ewes than they were in control ewes. Groups did not differ significantly in the protein and lactose content of their milk. In conclusion, melatonin treatment of ewes at lambing induced a high growth rate of their lambs and increased the fat content of the milk; however, the direct treatment with melatonin of the lambs at birth did not have an effect in their growth rate.

Effects of Melatonin on Dairy Herd Improvement (DHI) of Holstein Cow with High SCS

Mastitis is a common disease in cows breeding. The milk quality will be significantly reduced with increased milk somatic cells, which often occurs in cows with mastitis. In this study, the influence of seasonal changes, age and lactation stages in the Dairy Herd Improvement (DHI) of cows was investigated. Then, the Dairy Herd Improvement (DHI) of cows with high somatic cell score (SCS) after melatonin treatment was systemically investigated. The results showed that melatonin significantly suppressed the milk somatic cell score under all of the tested conditions. The melatonin treatment also improved the milk nutritional value by reducing its fat but increasing its lactose and protein contents. The application of melatonin significantly improved the DHI. The beneficial effects of melatonin on DHI are likely attributed to the antioxidant and anti-inflammatory activities of melatonin.